Abingworth as of Dec. 31, 2011
Portfolio Holdings for Abingworth
Abingworth holds 25 positions in its portfolio as reported in the December 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation | 36.6 | $59M | 7.9M | 7.48 | |
| Clovis Oncology | 11.3 | $18M | 1.3M | 14.01 | |
| Micromet | 9.3 | $15M | 2.1M | 7.17 | |
| Alnylam Pharmaceuticals (ALNY) | 9.2 | $15M | 1.8M | 8.14 | |
| Incyte Corporation (INCY) | 7.7 | $12M | 830k | 14.99 | |
| Astex Pharmaceuticals | 5.2 | $8.4M | 4.5M | 1.88 | |
| OncoGenex Pharmaceuticals | 4.4 | $7.0M | 604k | 11.67 | |
| Zogenix | 3.2 | $5.2M | 2.3M | 2.22 | |
| Nektar Therapeutics | 2.3 | $3.7M | 664k | 5.59 | |
| Alexza Pharmaceuticals | 1.5 | $2.4M | 2.9M | 0.82 | |
| Medicines Company | 1.2 | $2.0M | 107k | 18.64 | |
| Exelixis (EXEL) | 1.2 | $2.0M | 415k | 4.73 | |
| ISIS Pharmaceuticals | 1.2 | $1.9M | 268k | 7.20 | |
| Novavax | 1.2 | $1.9M | 1.5M | 1.24 | |
| Trimeris | 1.1 | $1.7M | 64k | 26.61 | |
| Cardiome Pharma Corp | 0.8 | $1.3M | 481k | 2.62 | |
| Isis Pharmaceuticals Inc Del note 2.625% 2/1 | 0.7 | $1.2M | 1.3k | 900.00 | |
| Zalicus | 0.6 | $1.0M | 864k | 1.20 | |
| Celldex Therapeutics | 0.6 | $886k | 343k | 2.58 | |
| Cornerstone Therapeutics | 0.3 | $473k | 85k | 5.58 | |
| Allos Therapeutics | 0.2 | $374k | 265k | 1.41 | |
| AVANIR Pharmaceuticals | 0.1 | $230k | 113k | 2.04 | |
| Sunesis Pharmaceuticals | 0.1 | $149k | 129k | 1.15 | |
| EntreMed | 0.0 | $67k | 71k | 0.95 | |
| Poniard Pharmaceuticals (PARD) | 0.0 | $10k | 4.6k | 2.19 |
